Article Details

AbbVie CEO summoned to Congress—again—to answer questions on Humira pricing, patenting

Retrieved on: 2021-04-30 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

AbbVie CEO summoned to Congress—again—to answer questions on Humira pricing, patenting. View article details on hiswai:

Excerpt

... House Oversight Committee tried repeatedly to obtain information on pricing and patenting strategies for AbbVie's top sellers Humira and Imbruvica.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo